A Sensitive High Performance Liquid Chromatography Assay for the Quantification of Doxorubicin Associated with DNA in Tumor and Tissues

Por Lucas, Andrew T., O’Neal, Sara K., Santos, Charlene M., White, Taylor F., Zamboni, William C.
Publicado no J Pharm Biomed Anal (2015)

Efficacy and pharmacodynamics of niraparib in BRCA-mutant and wild-type intracranial triple-negative breast cancer murine models

Por Sambade, Maria J, Van Swearingen, Amanda E D, McClure, Marni B, Deal, Allison M, Santos, Charlene, Sun, Kaiming, Wang, Jing, Mikule, Keith, Anders, Carey K
Publicado no Neurooncol Adv (2019)

A Novel Monoclonal Antibody to Secreted Frizzled Related Protein 2 Inhibits Tumor Growth

Por Fontenot, Emily, Rossi, Emma, Mumper, Russell, Snyder, Stephanie, Siamakpour-Reihani, Sharareh, Ma, Ping, Hilliard, Eleanor, Bone, Bradley, Ketelsen, David, Santos, Charlene, Patterson, Cam, Klauber-DeMore, Nancy
Publicado em 2013

Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast Cancer

Por Goulet, Daniel R., Foster, Joseph P., Zawistowski, Jon S., Bevill, Samantha M., Noël, Mélodie P., Olivares-Quintero, José F., Sciaky, Noah, Singh, Darshan, Santos, Charlene, Pattenden, Samantha G., Davis, Ian J., Johnson, Gary L.
Publicado no Mol Cancer Res (2020)

Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer

Por Anders, Carey K., Adamo, Barbara, Karginova, Olga, Deal, Allison M., Rawal, Sumit, Darr, David, Schorzman, Allison, Santos, Charlene, Bash, Ryan, Kafri, Tal, Carey, Lisa, Miller, C. Ryan, Perou, Charles M., Sharpless, Norman, Zamboni, William C.
Publicado em 2013

GSK2801, a BAZ2/BRD9 bromodomain inhibitor, synergizes with BET inhibitors to induce apoptosis in triple-negative breast cancer.

Por Bevill, Samantha M., Olivares-Quintero, Jose F., Sciaky, Noah, Golitz, Brian T., Singh, Darshan, Beltran, Adriana S., Rashid, Naim U., Stuhlmiller, Timothy J., Hale, Andrew, Moorman, Nathaniel J., Santos, Charlene M., Angus, Steven P., Zawistowski, Jon S., Johnson, Gary L.
Publicado no Mol Cancer Res (2019)

Effects of Tumor Microenvironment Heterogeneity on Nanoparticle Disposition and Efficacy in Breast Cancer Tumor Models

Por Song, Gina, Darr, David B., Santos, Charlene M., Ross, Mark, Valdivia, Alain, Jordan, Jamie L., Midkiff, Bentley R., Cohen, Stephanie, Feinberg, Nana Nikolaishvili, Miller, C. Ryan, Tarrant, Teresa K., Rogers, Arlin B., Dudley, Andrew C., Perou, Charles M., Zamboni, William C.
Publicado no Clin Cancer Res (2014)

Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer

Por Van Swearingen, Amanda E D, Sambade, Maria J, Siegel, Marni B, Sud, Shivani, McNeill, Robert S, Bevill, Samantha M, Chen, Xin, Bash, Ryan E, Mounsey, Louisa, Golitz, Brian T, Santos, Charlene, Deal, Allison, Parker, Joel S, Rashid, Naim, Miller, C Ryan, Johnson, Gary L, Anders, Carey K
Publicado no Neuro Oncol (2017)

Efficacy of carboplatin alone and in combination with ABT888 in intracranial murine models of BRCA-mutated and BRCA-wild-type triple negative breast cancer

Por Karginova, Olga, Siegel, Marni B., Van Swearingen, Amanda E. D., Deal, Allison M., Adamo, Barbara, Sambade, Maria J., Bazyar, Soha, Nikolaishvili-Feinberg, Nana, Bash, Ryan, O’Neal, Sara, Sandison, Katie, Parker, Joel S., Santos, Charlene, Darr, David, Zamboni, William, Lee, Yueh Z., Miller, C. Ryan, Anders, Carey K.
Publicado no Mol Cancer Ther (2015)

Enhancer Remodeling During Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacological Targeting of the P-TEFb Complex

Por Zawistowski, Jon S., Bevill, Samantha M., Goulet, Daniel R., Stuhlmiller, Timothy J., Beltran, Adriana S., Olivares-Quintero, Jose F., Singh, Darshan, Sciaky, Noah, Parker, Joel S., Rashid, Naim U., Chen, Xin, Duncan, James S., Whittle, Martin C., Angus, Steven P., Velarde, Sara Hanna, Golitz, Brian T., He, Xiaping, Santos, Charlene, Darr, David B., Gallagher, Kristalyn, Graves, Lee M., Perou, Charles M., Carey, Lisa A., Earp, H. Shelton, Johnson, Gary L.
Publicado no Cancer Discov (2017)